FDA Approved: MICAFUNGIN IN SODIUM CHLORIDE — Original Application (Baxter Healthcare Corporation)

View source ↗

Summary

FDA approved a new intravenous micafungin sodium formulation under Baxter's Original Application NDA, expanding antifungal treatment options.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Esophageal Candidiasis
• Invasive Candidiasis

Drugs mentioned

• Micafungin in Sodium Chloride (micafungin sodium)

Snippet

ORIG AP for MICAFUNGIN IN SODIUM CHLORIDE (MICAFUNGIN IN SODIUM CHLORIDE)